PTG
  • Home
  • Research
    • iBox technology
    • Publications
    • Collaborations
    • Granted Projects
    • Platforms
    • Database access
  • Team
  • News
    • Photo and Video Gallery
  • Job offers
  • PTG in the media
  • About

Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study

3/3/2020

 
Picture
The first universal algorithm for predicting the risk of kidney transplant loss, named iBox, has been developed, validated and just made public by teams from Europe and the US.

​The iBox is designed for clinicians to personalize and improve patient follow-up. The iBox could also accelerate the development of new immunosuppressive treatments by reducing the duration of clinical trials and defining a valid surrogate endpoint.
Chronic kidney disease affects 1 out of 10 people worldwide and is steadily increasing. When it reaches end-stage renal disease and endangers the lives of patients, dialysis or transplantation is required. ​
Renal transplantation is the treatment of choice, offering a better quality of life and survival chances to patients. Unfortunately, due to the lack of available organs, approximately 55% of patients with end-stage renal disease are still treated by dialysis, representing an annual cost of €2.6 billion in France and more than $40 billion in the USA.
The survival of kidney transplants is therefore crucial. As emphasized by regulatory agencies including the U.S. Food & Drug Administration and the European Medicines Agency, there is a substantial need to develop a robust tool that can predict long-term graft survival. Indeed, over the past 20 years, long-term graft survival did not improve. Therefore, implementing this prediction tool in clinical practice would facilitate therapeutic interventions by guiding clinical decision-making and would also facilitate clinical trials in kidney transplantation.

So far, no algorithm predicting long-term graft survival has been validated in different countries, populations and clinical scenarios, nor in the setting of randomized controlled trials.
Within this context, an international consortium gathering research teams from Europe and the US was created. Led by Professor Alexandre Loupy, head of the Paris Transplant Group, researchers looked at long-term patient data, and considered a wide variety of patient, donor and graft parameters. They thought that combining all these data into one prediction system with the use of artificial intelligence could lead to a robust integrative tool. 
Today, this ambitious initiative has succeeded.
The international research consortium has just developed the first universal tool for predicting the risk of kidney graft loss, called the iBox. Based on data easily available during patient follow-up after a kidney transplant, the tool generates probabilities of graft loss up to 10 years after patient evaluation. Tested on more than 7,500 patients, the predictions of this tool are highly reliable regardless of the health system, the clinical situation, the therapeutic intervention or the treatment of the patient.
"By optimizing medical decision-making, the use of the iBox could have a significant impact not only on the quality of life of each patient but also on the long-term survival of transplanted kidneys," explains Professor Alexandre Loupy, "This tool perfectly illustrates the potential of algorithms for decision making process in the field of organ transplantation. It will be deployed at the end of 2019 in two European transplant centers »
Apart from clinical use, the iBox could also contribute to the development of new treatments. Indeed, current clinical research in the field of kidney transplantation is limited. Unlike cancer treatments whose effectiveness can be evaluated over a shorter follow-up period, evaluating treatment effectiveness on graft survival requires trials that are years in duration.
​

The iBox should be able to significantly reduce the time - and therefore the cost - of these studies since it can provide an early-stage reliable prediction of the long-term graft survival. Thus, the iBox is emerging as a surrogate endpoint for the development of new clinical studies in kidney transplantation.
"The concept of the iBox goes far beyond kidney transplantation because of the already promising results in heart transplantation and cardiovascular disease," says Professor Xavier Jouven, Head of the Cardiovascular Division at the Georges Pompidou European Hospital in Paris, France.
Picture
Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study
Alexandre Loupy, Olivier Aubert, Babak J. Orandi, Maarten Naesens, Yassine Bouatou, Marc Raynaud, Gillian Divard, Annette M. Jackson, Denis Viglietti, Magali Giral, Nassim Kamar, Olivier Thaunat, Emmanuel Morelon, Michel Delahousse, Dirk Kuypers, Alexandre Hertig, Eric Rondeau, Elodie Bailly, Farsad Eskandary, Georg Böhmig, Gaurav Gupta, Denis Glotz, Christophe Legendre, Robert A. Montgomery, Mark D. Stegall, France Rein – Reseau Solidaire en action FNAIR, RENALOO, Jean-Philippe Empana, Xavier Jouven, Dorry L. Segev and Carmen Lefaucheur.
British Medical Journal, Sept 2019 - DOI:10.1136/bmj.l4923
Read the publication

Learn more

​Monitor patient after a kidney transplant with the iBox
​The iBox: a surrogate endpoint for clinical trials in the kidney transplantation field?
​Use case of iBox in clinical trials: predict long term graft survival at 10 years in post hoc study

COntact US

Submit

Comments are closed.

    Paris Transplant Group

    Our global aim is to accelerate the translation of immunological and gene expression discoveries into the clinical field by filling the gap between basic science and applied biomedical researches.

    CATEGORIES

    Awards
    Events
    Job offers
    Press Releases
    Publications

    See also

    Press coverage
    Video and ​Picture gallery

    ALl

    All
    Alexandre Loupy
    Antoine Bouquegneau
    Antoine Durrbach
    Antoine Roux
    Awards
    Blaise Robin
    Carmen Lefaucheur
    Charlotte Debiais
    Charlotte Loheac
    Christophe Legendre
    Daniel Yoo
    Dany Anglicheau
    Denis Glotz
    Denis Viglietti
    Elodie Bailly
    Events
    Gillian Divard
    Guillaume Bonnet
    Guillaume Coutance
    Huanxi Zhang
    Jean Luc Taupin
    Jean Paul Duong Van Huyen
    Jean Philippe Empana
    Jessy Dagobert
    Job
    Juliette Gueguen
    Kevin Louis
    Marc Raynaud
    Marie-Cécile Bories
    Marion Rabant
    Maud Racape
    Michel Delahousse
    Olivier Aubert
    Pascal Leprince
    Patrick Bruneval
    Peter Reese
    Press Releases
    Publications
    Shaida Varnous
    Valentin Goutaudier
    Xavier Jouven
    Yassine Bouatou
    Zeynep Demir

    Archives

    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    May 2020
    March 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    June 2019
    May 2019
    March 2019
    February 2019
    December 2018
    September 2018
    May 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    June 2016
    April 2016
    October 2015
    June 2015
    August 2014
    January 2014
    September 2013
    January 2013
    June 2011
    August 2010
    May 2009

    RSS Feed

Research

iBox technology
PTG Research
PTG Publications
Technical platforms​
Database resources
Covid-related research 🔓

Partnerships

Research collaborations
Technical platforms
​Database access
​

Paris Transplant Group

About PTG
PTG Team
​​Careers at PTG
​
Latest News
Video and Picture Gallery

PTG in the Press
​Contact us

Search

LEGAL NOTICE AND PRIVACY POLICY
© COPYRIGHT 2019. ALL RIGHTS RESERVED.

 LABS EXPLORER for the PARIS TRANSPLANT GROUP.
  • Home
  • Research
    • iBox technology
    • Publications
    • Collaborations
    • Granted Projects
    • Platforms
    • Database access
  • Team
  • News
    • Photo and Video Gallery
  • Job offers
  • PTG in the media
  • About